Baijin Life Science Holdings Limited
Baijin Life Science Holdings Limited (MNNGF) Revenue
Annual & quarterly revenue history · segment & region breakdown
MNNGF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsBaijin Life Science Holdings Limited trailing twelve-month (TTM) revenue is $0.22B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Baijin Life Science Holdings Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Baijin Life Science Holdings Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Baijin Life Science Holdings Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MNNGF revenue · 4 questionsMNNGF's trailing twelve-month (TTM) revenue is $0.22B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Baijin Life Science Holdings Limited SEC filings · GAAP · Baijin Life Science Holdings Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026